JEFFERSON (dpa-AFX) – A US jury has sentenced the pharmaceutical and agricultural company Bayer to pay more than 1.5 billion US dollars in a glyphosate trial. Three former users of the weed killer Roundup were awarded corresponding payments on Friday. They blamed the controversial product for their cancer. The federal court jury in Jefferson City, Missouri, awarded James Draeger, Valorie Gunther and Dan Anderson a total of $61.1 million in compensatory damages and $500 million each in punitive damages. In the United States, juries often award large sums to plaintiffs, which judges often later reduce.
Bayer said in a statement when asked: “Unlike previous cases, the courts in recent cases have improperly allowed plaintiffs to misrepresent the regulatory and scientific facts.” Bayer has “strong arguments” to have the latest judgments revised. The group has won nine of the last 13 court cases and settled the majority of the lawsuits. “We will continue to defend the robust scientific and regulatory evidence in court, if necessary on appeal,” said the DAX group. Bayer remained convinced of the safety of glyphosate.
Bayer brought the problems surrounding the weed killer Roundup, which contains glyphosate, into its own hands in 2018 with its $60 billion takeover of Monsanto. In the same year, the first judgment against the DAX (DAX 40) group followed, which set off a wave of lawsuits in the USA. In 2020, Bayer launched a billion-dollar program to settle the majority of the lawsuits – without admitting liability./jha/
Selected leverage products on Bayer
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Bayer
The leverage must be between 2 and 20
Advertising